Arrowstreet Capital, Limited Partnership Medpace Holdings, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 217,652 shares of MEDP stock, worth $76.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

217,652

Previous 237,349 8.3%

Holding current value

$76.4 Million

Previous $97.8 Million 25.75%

% of portfolio

0.06%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$320.58 - $457.29 $6.31 Million - $9.01 Million	-19,697 Reduced 8.3%	217,652 $72.6 Million
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $5.08 Million - $5.79 Million	-13,649 Reduced 5.44%	237,349 $97.8 Million
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $16.2 Million - $23.5 Million	56,899 Added 29.31%	250,998 $101 Million
Q4 2023 Feb 14, 2024	BUY	$227.52 - $312.68 $2.17 Million - $2.98 Million	9,521 Added 5.16%	194,099 $59.5 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $8.47 Million - $10.2 Million	36,207 Added 24.4%	184,578 $44.7 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $6.76 Million - $8.67 Million	36,085 Added 32.14%	148,371 $35.6 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $1.68 Million - $2.31 Million	9,638 Added 9.39%	112,286 $21.1 Million
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $6.44 Million - $9.54 Million	42,087 Added 69.5%	102,648 $21.8 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $2.74 Million - $3.44 Million	18,852 Added 45.2%	60,561 $9.52 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $1.22 Million - $1.57 Million	9,332 Added 28.82%	41,709 $6.24 Million
Q1 2022 May 13, 2022	SELL	$138.87 - $214.31 $23.1 Million - $35.7 Million	-166,481 Reduced 83.72%	32,377 $5.3 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $3.51 Million - $4.38 Million	-19,200 Reduced 8.8%	198,858 $43.3 Million
Q3 2021 Nov 12, 2021	BUY	$170.18 - $198.21 $5.98 Million - $6.97 Million	35,159 Added 19.22%	218,058 $41.3 Million
Q2 2021 Aug 13, 2021	BUY	$158.62 - $194.3 $12.6 Million - $15.4 Million	79,333 Added 76.6%	182,899 $32.3 Million
Q1 2021 May 14, 2021	SELL	$132.02 - $168.26 $11.8 Million - $15.1 Million	-89,733 Reduced 46.42%	103,566 $17 Million
Q4 2020 Feb 12, 2021	SELL	$109.38 - $149.19 $7.88 Million - $10.8 Million	-72,083 Reduced 27.16%	193,299 $26.9 Million
Q3 2020 Nov 12, 2020	SELL	$92.95 - $130.61 $2.07 Million - $2.91 Million	-22,261 Reduced 7.74%	265,382 $29.7 Million
Q2 2020 Aug 12, 2020	SELL	$68.08 - $95.68 $735,808 - $1.03 Million	-10,808 Reduced 3.62%	287,643 $26.8 Million
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $2.55 Million - $4.21 Million	-41,313 Reduced 12.16%	298,451 $21.9 Million
Q4 2019 Feb 13, 2020	BUY	$70.08 - $84.64 $19.2 Million - $23.1 Million	273,504 Added 412.77%	339,764 $28.6 Million
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $4.13 Million - $5.69 Million	66,260 New	66,260 $5.57 Million
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $609,694 - $871,451	-12,347 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$46.97 - $63.98 $9.04 Million - $12.3 Million	-192,371 Reduced 93.97%	12,347 $654,000
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $5.5 Million - $8.11 Million	127,264 Added 164.31%	204,718 $12.3 Million
Q2 2018 Aug 14, 2018	BUY	$34.03 - $45.46 $1.97 Million - $2.63 Million	57,940 Added 296.92%	77,454 $3.33 Million
Q1 2018 May 14, 2018	BUY	$32.03 - $39.05 $183,627 - $223,873	5,733 Added 41.6%	19,514 $681,000
Q4 2017 Feb 09, 2018	BUY	$32.46 - $38.31 $447,331 - $527,950	13,781	13,781 $500,000

Others Institutions Holding MEDP

# of Institutions

615

Shares Held

25M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.9B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Medpace Holdings, Inc. Transaction History